MLYCD and infarction: Recently, an acute inhibition of malonyl-CoA decarboxylase (MCD) (potentiating the malonyl-CoA-dependent inhibition of FFA entry to the mitochondria) resulted in a switch from FFA to glucose utilization in normal rat hearts, and improved EF and SV in post-infarction failing hearts [28].